Objectives: Pulmonary hypertension (PH) has been associated with decreased functional capacity in patients with advanced idiopathic pulmonary fibrosis (IPF). We aimed to evaluate the true impact of altered pulmonary hemodynamics on functional capacity in a cohort of patients with IPF. Methods: Between January 1990 and December 2007, 124 patients [73M/51F; 111 Caucasians] with IPF underwent right heart catheterization and 6-min walk test (6MWT). Pulmonary arterial hypertension (PAH) was defined as mPAP ! 25 and pulmonary artery occlusion pressure (PAOP) 15 mmHg, and Pre-PH as mPAP > 20 and <25 mmHg with PAOP < 15 mmHg. Demographic, hemodynamic, spirometric, and 6MWT data were collected. Results: Fifty four (44%) patients had PH. There were no significant differences between the PH and the non-PH groups in measures of pulmonary function other than PaO 2 . Patients with PH and PAH had significantly lower 6-min walk distance (6MWD) (p Z 0.008 and p Z 0.03 respectively) and distance saturation product (DSP) (p Z 0.002 and p Z 0.006 respectively) compared to non-PH patients. Mean pulmonary arterial pressure (mPAP) was the best predictor of 6MWD by multivariate analysis (p Z 0.0006). Increasing mPAP was associated with a statistically significant decline in 6MWD (p Z 0.02) and DSP (p Z 0.01). Patients with 'Pre-PH' had lower 6MWD compared to patients with mPAP 20 mmHg (p Z 0.07).
Introduction
Patients with diffuse parenchymal lung diseases have increased shortness of breath and reduced functional capacity compared to those without lung diseases. These restrictions may be a result of compromise in lung function, hypoxia, and the presence of pulmonary vascular disease. 1 Currently, there is no effective medical therapy and patients with idiopathic pulmonary fibrosis (IPF) have a very high mortality rate when awaiting lung transplantation. 2e5 Major factors associated with an increased risk of death include older age, and reduction in lung function and exercise capacity. 6e11 Studies have indicated that reduced 6-min walk distance (6MWD) 12, 13 and desaturation during the 6-min walk test (6MWT) 6 ,14e16 may also be important predictors of survival in IPF.
Recently, the presence of pulmonary hypertension (PH) has been implicated as a factor in reduced survival. 4 Reports suggest that the presence of PH may be associated with reduced functional capacity (as measured by 6MWD); however, these studies have several limitations including small sample size, 4 ,17 lack of accurate characterization of IPF, 12 variability in methodology of 6MWD measurement, 12 and lack of or inadequate hemodynamic characterization. 7, 12, 13, 18 Additionally, due to sample size and methodologic limitations, previous studies have not evaluated the influence, if any, of mild abnormalities in pulmonary hemodynamics ('Pre-PH') 19 on functional capacity. Given the impact of PH, it is somewhat surprising that there is not a single study, of adequate sample size, evaluating the relative impact of pulmonary function and well-characterized pulmonary hemodynamics in a cohort of patients with IPF. The recent ATS Guidelines for the diagnosis and management of IPF 20 recommend that 'variables assessed during the 6MWT warrant additional study'. In the spirit of this recommendation we performed this study to evaluate the impact of altered pulmonary hemodynamics on functional capacity in a larger cohort of patients with IPF and well-characterized pulmonary hemodynamics.
Methods Subjects
The study was approved by the Cleveland Clinic Institutional Review Board (IRB number 07-001) and data was also obtained from the Cleveland Clinic Lung Transplant Database (IRB number 06-167). Patient consent was not obtained since this was a retrospective data review and required no patient contact. We performed a crosssectional analysis of a retrospective cohort of consecutive patients with IPF who were evaluated for lung transplantation at our institution from January 1990 through December 2007. All adult patients with IPF who underwent right heart catheterization and a 6MWT as part of their transplant evaluation were included. The diagnosis of IPF was established using standard criteria. 20, 21 A surgical lung biopsy was not required for confirmation; however, in some patients the diagnosis was established by this means. To assure relatedness of the non-invasive tests to the right heart catheterization, if patients had multiple non-invasive evaluations, the ones closest to the right heart catheterization were chosen for analysis.
Data collection
All variables were collected from the Cleveland Clinic lung transplant database and/or the patients' medical records. Pulmonary function testing was performed according to American Thoracic Society standards. 22 Lung volumes were determined by plethysmography. Predicted normal values for pulmonary function testing were determined using a single set of standardized equations.
23e25 Arterial blood gas measurement was performed, with the patient breathing ambient air. The 6MWTs were conducted in accordance with the recommendations of the American Thoracic Society. 26 Data pertaining to left ventricular ejection fraction and right sided pressures were obtained from transthoracic echocardiograhic testing. Right heart catheterization was performed with patients at rest in the supine position.
Definitions
Pulmonary hypertension was defined as a mean pulmonary arterial pressure (mPAP) ! 25 mmHg by right heart catheterization. 19 Pulmonary arterial hypertension (PAH) was defined as mPAP ! 25 mmHg and pulmonary artery occlusion pressure [PAOP] 15 mmHg, pulmonary venous hypertension (PVH) was defined as mPAP ! 25 mmHg and PAOP > 15 mmHg. Non-PH was defined as mPAP 20 mmHg and Pre-PH was defined as mPAP > 20 mmHg and <25 mmHg with PAOP 15 mmHg. 19 Distance saturation product (DSP) was calculated as previously described, 14 and was defined as the product of the final distance walked, in meters, and the lowest room air oxygen saturation. Pulmonary capacitance was defined as stroke volume/pulse pressure. It is important to keep in mind that the term "PAH" as used in this manuscript simply implies the presence of "pre-capillary pulmonary hypertension" to separate this from PVH or "postcapillary pulmonary hypertension" based on pulmonary hemodynamics. This should not be taken to mean that the authors believe that patients designated as "PAH" are members of World Health Organization Group I PH.
Statistical analysis
Analyses were performed to evaluate the impact of abnormal pulmonary hemodynamics on functional capacity (as measured by the 6MWT). Continuous measurements were described as means AE standard deviations and were compared using the KruskaleWallis test. Categorical measurements were summarized using frequencies and percentages and were compared using Pearson Chi-Square test. Correlations were calculated between pulmonary hemodynamic parameters and measures of pulmonary function, oxygenation, and 6MWD. Patients were divided into quartiles of mPAP to aid in describing the association of worsening hemodynamics with measures of pulmonary function, oxygenation, and 6MWD.
Multivariable regression analysis was used to identify patient variables associated with 6MWD. All demographic, hemodynamic, and pulmonary function variables that had at least 75% values in the dataset were included in the analysis. Sporadic missing values were imputed using means substitution. Bootstrap aggregation (bagging) was used for variable selection, 27 with p < 0.07 for entry into the model and p < 0.05 for variable retention. Variables appearing in at least 50% of bootstrap analyses were considered reliably statistically significant at p < 0.05 (median rule). SAS 9.1.3 software (SAS Institute, Cary, North Carolina) was used for all analyses.
Results

Overall population characteristics
A total of 124 adult IPF patients undergoing evaluation for lung transplantation met criteria and were included in our analysis (Tables 1 and 2 ). There were no significant differences between the PH and the non-PH groups in terms of demographics or measures of pulmonary function other than PaO 2 . Patients with PH had significantly lower 6MWD and DSP compared with non-PH patients. As expected, hemodynamics were significantly different between the 2 groups. In addition, patients with PH were significantly more likely to have a cardiac index < 2 and lower pulmonary capacitance compared to the non-PH group. Compared to non-PH patients, those with PAH (Table 3 ) had lower PaO 2 , 6MWD, and DSP and were more likely to have a cardiac index < 2 and reduced pulmonary capacitance. No significant differences were seen in terms of parameters of pulmonary function. Compared to patients 
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with PVH, those with PAH had a lower body mass index, a higher pulmonary vascular resistance, and reduced pulmonary capacitance. There were no significant differences in 6MWD or DSP.
Association between pulmonary hemodynamics and functional capacity
There was a significant correlation between 6MWD and DLCO % predicted, room air PaO 2 , mRAP, mPAP, sPAP, and PVR ( Fig. 1 and Table 1 online supplement). Similarly DSP was significantly correlated with DLCO % predicted and room air PaO 2 and with mRAP, mPAP, sPAP, and PVR. DSP showed a small but significant correlation with cardiac index (r Z 0.2; p Z 0.04) whereas 6MWD did not (r Z 0.1; p Z 0.1) (Fig. 2 and Table 1 online supplement) . By multivariate analysis, the best predictors of 6MWD were mPAP and being of Caucasian origin (Table 4 ). Each increase of 1 mmHg in mPAP was associated with a 2.6 m decrease in 6MWD (p Z 0.0006). Patients of White race walked approximately 56 m further than those of other races (p Z 0.03; only marginally confirmed by the bootstrap). When analyzing by quartiles of mPAP (Table 5 and Fig. 3 ), we found that increasing mPAP was associated with a statistically significant decline in 6MWD and DSP. The decline in room air PaO 2 did not reach statistical significance. Rising mPAP was not associated with significant changes in demographic variables or measures of pulmonary function.
When patients were divided into those with PAOP 15 mmHg and those with PAOP > 15 mmHg patients with PAOP 15 mmHg (Fig. 4) showed a large decrease in 6MWD between those with mPAP 20 mmHg (non-PH) and those with mPAP > 20 and <25 mmHg (Pre-PH) (p Z 0.07) and there was very little difference in 6MWD between the Pre-PH and the mild to moderate PH groups (p Z 0.6). Patients with PAOP > 15 mmHg did not show similar changes (Online supplement Tables 2a and 2b ).
Discussion
Our study advances the current literature regarding 6MWT and pulmonary hemodynamics in patients with IPF in several ways. This is the first study to evaluate the relative impact of well-characterized pulmonary hemodynamics and measures of pulmonary function on functional capacity in patients with IPF. We found that relative to measures of pulmonary function and hypoxia, altered pulmonary hemodynamics had a greater impact on 6MWD in these patients.
The impact of altered pulmonary hemodynamics on 6MWD in IPF has been previously evaluated, and patients with PH were found to have reduced 6MWD compared to patients without PH. 4, 12 However, due to several limitations, including small sample size, 4,17 missing pulmonary function measures, or inadequate hemodynamic characterization, 12, 18 these studies have been unable to look at the relative impact of altered pulmonary hemodynamics and measures of pulmonary function and hypoxia on functional capacity. The larger studies with 6MWT data in IPF have either not had access to pulmonary hemodynamic data 13 or had access to incomplete hemodynamic data. 7, 12, 18 As such, studies have typically concluded that both factors are altered and relevant to functional compromise. In our cohort, mPAP was the only measure of pulmonary hemodynamics or pulmonary function that was independently associated with 6MWD by multivariate 
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analysis. In addition, previous studies have not looked at the impact of increasing mPAP on 6MWD largely due to small sample size and lack of accurate hemodynamic data. We found that higher mPAP was associated with more significant exercise impairment in patients with IPF. These findings together have significant implications for the contribution of pulmonary vascular disease to functional limitation in patients with IPF.
Publications evaluating PH in the setting of IPF have typically utilized the standard definition of PH (mPAP > 25 mmHg) and have compared those with PH to those without PH. Recent PH guidelines have modified the definition of PH to those with mPAP ! 25 mmHg and have identified another sub-group of patients as 'Pre-PH' (those with mPAP > 20 mmHg and <25 mmHg 19 ) indicating that these patients have altered pulmonary hemodynamics but the true significance of this abnormality requires further study. In our cohort we have utilized the new standard definition of PH and have evaluated the impact of mildly abnormal pulmonary hemodynamics in the 'Pre-PH' group. This is the first study to report that these patients had lower 6MWD and DSP compared to patients with mPAP < 20 mmHg indicating that these mild abnormalities in pulmonary hemodynamics may be having a negative effect on functional capacity in patients with IPF. This may be a reflection of the fact that the impact of worsening pulmonary hemodynamics is a continuous measure and dichotomous definitions that use artificial cut-off values are inherently flawed. Just as interestingly, there was only a minor difference in 6MWD between those with Pre-PH and those with mild to moderate PH. These findings are confirmed by the linear negative correlation between 6MWD and DSP and pulmonary hemodynamics including mPAP, sPAP, and PVR and suggest that the impact of elevated pulmonary arterial pressure on exercise limitation is incremental and not determined by an arbitrary threshold. Larger cohorts of patients with Pre-PH need to be studied to confirm this finding and to further evaluate its clinical significance in limiting functional capacity. Another interesting point is that those with Pre-PH had a 40 m mean reduction in 6MWD compared to patients with mPAP 20 mmHg. This difference in 6MWD is close to the upper threshold of the minimally clinically important difference for 6MWD recently reported for patients with IPF (between 24 and 45 m). 13 This suggests that the difference in 6MWD between those with mPAP 20 mmHg and those with Pre-PH may be clinically significant.
This study strengthens the link between functional limitation, exertional hypoxia, and pulmonary hemodynamics in patients with IPF. This is the first study to report that patients with PH, in the setting of IPF, have reduced DSP compared to patients without PH, and that increasing pulmonary arterial pressures are associated with declining DSP. Several previous studies in IPF have reported the association between exercise desaturation and reduced survival 6,14e16 independent of pulmonary function. One previous study has identified a composite measure (DSP) as a significant predictor of prognosis.
14 Unfortunately pulmonary hemodynamics were not included in that study. Our study indicates that the lower DSP could have been a surrogate marker for PH in that population.
The lack of association between pulmonary function variables such as FVC % predicted and pulmonary hemodynamic abnormalities has been previously reported and was confirmed in our cohort. 6, 28 Similar to previous reports, patients with more hemodynamic abnormalities did have lower DLCO % predicted compared to patients without PH; however, this difference did not reach statistical significance. 28 When dividing patients into quartiles of mPAP it was evident that there was no significant difference in terms of measures of pulmonary function between those without PH and those with significant PH.
Increasing mPAP was associated with higher PAOP but was also associated with increasing PVR and pulse pressure and decreasing pulmonary capacitance. Increased pulse pressure and reduced pulmonary capacitance have been associated with reduced functional capacity and survival in patients with pulmonary arterial hypertension. 29, 30 This is the first study to show that similar hemodynamic abnormalities are present in patients with IPF; however, their significance (if any) requires further study. Even though patients with PH had lower 6MWD and DSP compared to patients without PH, it was interesting to 6-Min walk test and PH in IPFnote that patients with PAOP 15 mmHg had a decline in 6MWD and DSP with increasing mPAP unlike patients with PAOP > 15 mmHg. Our study has the limitations of a retrospective, crosssectional design. In addition, patients included in the study had mostly advanced IPF and were being evaluated for lung transplantation so these results may not be applicable to the IPF population as a whole.
In conclusion, we found that relative to measures of pulmonary function and hypoxia, altered pulmonary hemodynamics had a greater impact on 6MWD in patients with IPF, that higher mPAP was associated with more significant exercise impairment, and that mild abnormalities in pulmonary hemodynamics (so called 'Pre-PH') were also associated with a significant reduction in functional capacity. Figure 4 Impact of Pre-PH on 6MWD and distance saturation product among patients with pulmonary artery occlusion pressure 15 mmHg.
